CoChat

Patient-reported outcomes before and after treatment of major depressive disorder

Open access
IsHak, Waguih William, Mirocha, James, Pi, Sarah, Tobia, Gabriel, Becker, Bret, Peselow, Eric D., Cohen, Robert M. · 2014 · Dialogues in Clinical Neuroscience
Cited by 45

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Patient reported outcomes (PROs) of quality of life (QoL), functioning, and depressive symptom severity are important in assessing the burden of illness of major depressive disorder (MDD) and to evaluate the impact of treatment. We sought to provide a detailed analysis of PROs before and after treatment of MDD from the large Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. This analysis examines PROs before and after treatment in the second level of STAR*D. The complete data on QoL, functioning, and depressive symptom severity, were analyzed for each STAR*D level 2 treatment. PROs of QoL, functioning, and depressive symptom severity showed substantial impairments after failing a selective serotonin reuptake inhibitor trial using citalopram (level 1). The seven therapeutic options in level 2 had positive statistically (P values) and clinically (Cohen's standardized differences [Cohen's d]) significant impact on QoL, functioning, depressive symptom severity, and reduction in calculated burden of illness. There were no statistically significant differences between the interventions. However, a substantial proportion of patients still suffered from patient-reported QoL and functioning impairment after treatment, an effect that was more pronounced in nonremitters. PROs are crucial in understanding the impact of MDD and in examining the effects of treatment interventions, both in research and clinical settings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.31887/dcns.2014.16.2/rcohen

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 33

  1. Murray CJ., 1997, Lancet., 349, 1498, 10.1016/S0140-6736(96)07492-2 · DOI · Paper page
  2. Kessler RC., 2005, Arch Gen Psychiatry., 62, 617, 10.1001/archpsyc.62.6.617 · DOI · Paper page
  3. Zung WW., 1993, J Fam Pract., 37, 337
  4. Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI). Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective., 2012, JAMA., 307, 1636, 10.1001/jama.2012.466 · DOI · Paper page
  5. Aigner M., 2006, Soc Psychiatry Psychiatr Epidemiol., 41, 81, 10.1007/s00127-005-0997-8 · DOI
  6. Berlim M., 2007, Quality of Life impairment in Schizophrenia, Mood, and Anxiety Disorders. Dordrecht, the Netherlands: Springer.
  7. Moore M., 2005, Health Qual Life Outcomes., 3, 1, 10.1186/1477-7525-3-1 · DOI
  8. Peselow ED., 2014, Int Clin Psychopharmacol., 29, 111, 10.1097/YIC.0000000000000015 · DOI
  9. Rush AJ., 1987, J Clin Psychiatry., 48, 246
  10. Pyne JM., 1997, Psychiatr Serv., 48, 224, 10.1176/ps.48.2.224 · DOI · Paper page
  11. Ritsner M., 2007, Quality of Life Impairment in Schizophrenia, Mood, and Anxiety Disorders. Dordrecht, the Netherlands: Springer;, 10.1007/978-1-4020-5779-3 · DOI
  12. Endicott J., 1993, Psychopharmacol Bull., 29, 321
  13. Ware JE., 1992, Med Care., 30, 473, 10.1097/00005650-199206000-00002 · DOI · Paper page
  14. The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties., 1998, Soc Sci Med., 46, 1569, 10.1016/S0277-9536(98)00009-4 · DOI · Paper page
  15. EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life., 1990, Health Policy., 16, 199, 10.1016/0168-8510(90)90421-9 · DOI · Paper page
  16. Sheehan DV., 1983, The Anxiety Disease. New York, NY: Charles Scribner & Sons., 151
  17. Endicott J., 1997, Psychopharmacol Bull., 33, 13
  18. Rush AJ., 2003, Biol Psychiatry., 54, 585, 10.1016/S0006-3223(03)00786-8 · doi:10.1016/s0006-3223(03)00786-8
  19. Beck AT., 1996, Manual for the Beck Depression Inventory-ll. San Antonio, TX: Psychological Corporation..
  20. Zimmerman M., 2008, Compr Psychiatry., 49, 131, 10.1016/j.comppsych.2007.10.006 · DOI · Paper page
  21. Radloff LS., 1977, Appl Psychol Measures., 1, 385, 10.1177/014662167700100306 · DOI · Paper page
  22. Spitzer R., 1999, JAMA., 282, 1737, 10.1001/jama.282.18.1737 · DOI · Paper page
  23. Teresi JA., 2009, Psychol SciQ., 51, 148
  24. IsHak WW., 2013, Adm Policy Ment Health., 40, 76, 10.1007/s10488-011-0376-6 · DOI · Paper page
  25. Fava M., 2003, Psychiatr Clin North Am., 26, 457, 10.1016/S0193-953X(02)00107-7 · DOI · Paper page
  26. Mundt JC., 2002, Br J Psychiatry., 180, 461, 10.1192/bjp.180.5.461 · DOI · Paper page
  27. IsHak WW., 2013, Qua I Life Res., 22, 585, 10.1007/s11136-012-0187-6 · DOI
  28. Lavori PW., 2001, Biol Psychiatry., 50, 792, 10.1016/S0006-3223(01)01223-9 · DOI
  29. Gaynes BN., 2008, Cleve Clin J Med., 75, 57, 10.3949/ccjm.75.1.57 · DOI · Paper page
  30. Schecter LE., 2005, NeuroRx., 2, 590, 10.1602/neurorx.2.4.590 · DOI · Paper page
  31. Warden D., 2009, Int J Neuropsychopharmacol., 12, 459, 10.1017/S1461145708009073 · DOI · Paper page
  32. Warden D., 2009, Depress Anxiety., 26, 622, 10.1002/da.20541 · DOI · Paper page
  33. Gaynes BN., 2011, Depress Anxiety., 28, 989, 10.1002/da.20898 · DOI

Cited by

See all 45

Metadata

Authors
IsHak, W. W., Mirocha, J., Pi, S., Tobia, G., Becker, B., Peselow, E. D., & Cohen, R. M.
Venue
Dialogues in Clinical Neuroscience
Published
2014-06-30
Volume
16
Issue
2
Pages
171-183
ISSN
  • 1294-8322 (ISSN-L)
  • 1958-5969
OpenAlex
W4322700626
Cited by
45
References
17
FWCI
2.16
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patient-reported outcomes before and after treatment of major depressive disorder. https://app.cochat.ai/papers/10.31887/dcns.2014.16.2/rcohen
The paper
IsHak, W. W., Mirocha, J., Pi, S., Tobia, G., Becker, B., Peselow, E. D., & Cohen, R. M. (2014). Patient-reported outcomes before and after treatment of major depressive disorder. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2014.16.2/rcohen

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.